Dr. Michael Roizen, MD

Bio

Michael F. Roizen, MD, a Sharecare Editorial Advisory member, is a Phi Beta Kappa graduate of Williams College, Alpha Omega Alpha graduate of the University of California, San Francisco, School of Medicine, and is board certified in both Anesthesiology and Internal Medicine. In 2007 Dr. Roizen was named the Chief Wellness Officer (the first such position in a major healthcare institution in the United States) for Cleveland Clinic, and Chair of its Wellness Institute. Dr. Roizen co-founded RealAge and chairs its Scientific Advisory Board. He is 64 calendar years of age, but his RealAge is 44.3. He and Dr Oz have authored 8 NY Times bestsellers between them, and three separately, including 4 #1 NY Times Bestsellers, including RealAge, Are You As Young As You Can Be, YOU: The Owner’s Manual, YOU: On A Diet, the Owner’s Manual for Waist Management, and YOU Staying Young, the Owner’s Manual for Extending Your Warranty.

Specialties:

Affiliation:

  • Cleveland Clinic

Location:

Activity

  • Sharecare News
    Sharecare News posted a story about Pediatrics:

    FRIDAY, Feb. 7, 2014 (HealthDay News) -- Teens who drink high-caffeine energy beverages such as Red Bull or Monster may be more likely to use alcohol, drugs and cigarettes, a new study suggests.

    The findings suggest that the same personality traits that attract kids to energy drinks -- su...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology/diabetes/metabolism:

    THURSDAY, Feb. 6, 2014 (HealthDay News) -- People who suffer acute kidney damage due to surgery are at increased risk for developing heart problems. And the level of risk is comparable to that caused by diabetes, a new study finds.

    Patients sometimes suffer acute kidney injuries after maj...Full Article

  • Sharecare News
    Sharecare News posted a story about Neurology:

    THURSDAY, Feb. 6, 2014 (HealthDay News) -- For the first time, guidelines have been created to help prevent stroke in women.

    The author of the new guidelines, published online Feb. 6 and in the May print issue of the journal Stroke, said women share a lot of stroke risk factors wit...Full Article

  • Sharecare News
    Sharecare News posted a story about Neurology:

    THURSDAY, Feb. 6, 2014 (HealthDay News) -- A small new study suggests that the brains of children with autism churn busily when they seem to be not doing anything -- potentially explaining why people with autism often seem lost in their own inner worlds.

    The findings don't definitively l...Full Article

  • Sharecare News
    Sharecare News posted a story about Neurology:

    THURSDAY, Feb. 6, 2014 (HealthDay News) -- A small new study suggests that the brains of children with autism churn busily when they seem to be not doing anything -- potentially explaining why people with autism often seem lost in their own inner worlds.

    The findings don't definitively l...Full Article

  • Sharecare News
    Sharecare News posted a story about Pediatric Neurology:

    THURSDAY, Feb. 6, 2014 (HealthDay News) -- Infants who shifted their gaze from faces of people who were speaking were more likely to be diagnosed with autism when they were older, a new study reveals.

    This is the first time that this type of abnormal response to...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology/diabetes/metabolism:

    THURSDAY, Feb. 6, 2014 (HealthDay News) -- In a potential breakthrough for the treatment of type 1 diabetes, researchers have successfully turned mouse skin cells into insulin-producing beta cells.

    And when those cells were transplanted into a few dozen diabetic mice, their blood sugar le...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology/diabetes/metabolism:

    THURSDAY, Feb. 6, 2014 (HealthDay News) -- In a potential breakthrough for the treatment of type 1 diabetes, researchers have successfully turned mouse skin cells into insulin-producing beta cells.

    And when those cells were transplanted into a few dozen diabetic mice, their blood sugar le...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology/diabetes/metabolism:

    THURSDAY, Feb. 6, 2014 (HealthDay News) -- In a potential breakthrough for the treatment of type 1 diabetes, researchers have successfully turned mouse skin cells into insulin-producing beta cells.

    And when those cells were transplanted into a few dozen diabetic mice, their blood sugar le...Full Article

  • Sharecare News
    Sharecare News posted a story about Neurology:

    THURSDAY, Feb. 6, 2014 (HealthDay News) -- Early treatment with antiepileptic drugs reduces the length of fever-related seizures in children, according to a new study.

    Published Feb. 6 in the journal Epilepsia, the study also found that a standard emergency medical services treatme...Full Article

  • Sharecare News
    Sharecare News posted a story about Neurology:

    THURSDAY, Feb. 6, 2014 (HealthDay News) -- Early treatment with antiepileptic drugs reduces the length of fever-related seizures in children, according to a new study.

    Published Feb. 6 in the journal Epilepsia, the study also found that a standard emergency medical services treatme...Full Article

  • Sharecare News
    Sharecare News posted a story about Neurology:

    THURSDAY, Feb. 6, 2014 (HealthDay News) -- Early treatment with antiepileptic drugs reduces the length of fever-related seizures in children, according to a new study.

    Published Feb. 6 in the journal Epilepsia, the study also found that a standard emergency medical services treatme...Full Article

  • Sharecare News
    Sharecare News posted a story about Hematology:

    WEDNESDAY, Feb. 5, 2014 (HealthDay News) -- An experimental drug appears to prevent dangerous blood clots, without raising the risk of excessive bleeding -- at least in animals.

    Scientists found that an injectable antibody protected rabbits from developing blood clots but didn't cause ble...Full Article

  • Sharecare News
    Sharecare News posted a story about Hematology:

    WEDNESDAY, Feb. 5, 2014 (HealthDay News) -- An experimental drug appears to prevent dangerous blood clots, without raising the risk of excessive bleeding -- at least in animals.

    Scientists found that an injectable antibody protected rabbits from developing blood clots but didn't cause ble...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    WEDNESDAY, Feb. 5, 2014 (HealthDay News) -- Large doses of intravenous vitamin C have the potential to boost chemotherapy's ability to kill cancer cells, according to new laboratory research involving human cells and mice.

    Vitamin C delivered directly to human and mouse ovarian cancer cel...Full Article